Aggregator
A replaceable soma enables negative senescence in harvester ants
Most vertebrates and insects undergo senescence: as they age, their rate of mortality increases while reproduction declines. We present data from a 34-y study on 3,285 colonies of known age in the western harvester ant, Pogonomyrmex occidentalis, that show the reverse pattern, negative senescence, in which mortality decreases and reproduction increases with age. Theoretical models have identified indeterminate growth and a lack of reproductive cost to growth as the key traits favoring the...
Senescence-Associated Loss of alpha-Synuclein in Brain Microvascular Endothelium Compromises Tight Junctions and Disrupts Blood-Brain Barrier Integrity
Blood-brain barrier (BBB) dysfunction is an early feature of brain aging, but the endothelial mechanisms preserving barrier resilience remain unclear. Although we have reported α-synuclein (SNCA) supports vascular endothelial homeostasis, its role in the brain microvascular endothelium is unknown. Because SNCA loss suppresses eNOS/NO signaling and promotes endothelial β-site amyloid precursor protein cleaving enzyme 1 (BACE1) induction, we investigated whether senescence-associated SNCA decline...
Scientists discover a surprising link between acorns and lyme disease
After more than 35 years of research, scientists have uncovered surprising clues about what really drives Lyme disease risk. Contrary to longstanding assumptions, deer populations appear less important than mice, which can fuel a 40% increase in tick numbers the following year. Even acorn production can predict tick population surges two years in advance, while extreme temperatures may be far less deadly to ticks than scientists once believed.
A simple supplement may help clear brain fog after cancer
A surprising new study from UCLA suggests that a naturally occurring molecule could help breast cancer survivors overcome the frustrating brain fog and exhaustion that can linger long after treatment ends. Researchers found that women taking an oxaloacetate supplement for eight weeks experienced substantial improvements in memory, concentration, mental clarity, and fatigue.
AI beats scientists at finding errors in clinical research papers
New findings demonstrate AI’s aptitude for identifying technical flaws in studies where medical decisions are on the line
Daily briefing: The ‘overshoot COP’ kicks off
How to make failure your friend and teacher in science
What postdoc ads ask for and what they leave unsaid
How academic freedom is changing around the world — by the numbers
Author Correction: Histone H3 trimethylation at lysine 36 guides m<sup>6</sup>A RNA modification co-transcriptionally
He spent a year on ‘Mars’: NASA science officer emerges from mock mission
AI has transformed maths — this is how we got here
Carlo Rovelli says fundamental physics is overrated
The super El Niño is more than a climate shock – it’s a health one, too
COP31 kicks off as planet faces imminent overshoot of 1.5 °C climate target
Common osteoporosis drugs linked to 24% lower dementia risk in major study
A massive study of more than 120,000 older adults suggests that common osteoporosis drugs may reduce the risk of Alzheimer’s disease and other dementias by up to 24%. The surprising findings raise the possibility that medications already used to strengthen bones could also help protect the aging brain.
Neurons in a dish are the newest computing machines
Brain organoids offer highly efficient processing—if researchers can learn how to harness their power
To deter bioterrorism, U.S. imposes new rules on ordering synthetic DNA
New policy draws tempered praise from biosecurity experts
A little-known protein could be a major culprit in type 2 diabetes
Scientists have discovered that a buildup of a protein called Miro1 may be a hidden driver of insulin resistance in Type 2 diabetes, with preclinical experiments showing that removing it restores the muscles’ response to insulin. Exercise was also found to lower Miro1 levels in people with diabetes, revealing a potential new pathway for treating the disease.
Scientists wipe out deadly brain tumors in every mouse tested with new cancer therapy
Scientists at UC San Francisco have developed a powerful new cancer therapy that remains inactive until it reaches the brain, where it switches on to attack deadly tumors. The engineered immune cells, called B-SYNC CAR-T cells, completely eliminated diffuse midline glioma (DMG), an aggressive childhood brain cancer that is almost always fatal within a year, in two mouse models.